Martin Zeier
About
In The Last Decade
Martin Zeier
305 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Transplantation 3.2k
- Surgery 2.6k
- Nephrology 2.1k
- Public Health, Environmental and Occupational Health 1.7k
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Martin Zeier
This map shows the geographic impact of Martin Zeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Zeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Zeier more than expected).
Fields of papers citing papers by Martin Zeier
This network shows the impact of papers produced by Martin Zeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Zeier. The network helps show where Martin Zeier may publish in the future.
Co-authorship network of co-authors of Martin Zeier
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Zeier. A scholar is included among the top collaborators of Martin Zeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Zeier. Martin Zeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 9 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 23 | |
| 9 | 15 | |
| 10 | 36 | |
| 11 | 38 | |
| 12 | 5 | |
| 13 | 6 | |
| 14 | 45 | |
| 15 | 99 | |
| 16 | 65 | |
| 17 | 46 | |
| 18 | 18 | |
| 19 | Reduced cyclosporine exposure is safe and efficacious in combination with basiliximab, enteric-coated mycophenolate-sodium, and steroids. | 4 |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.